Erasca, Inc.

Informe acción NasdaqGS:ERAS

Capitalización de mercado: US$768.1m

Dividendos de Erasca

Dividendo controles de criterios 0/6

Erasca does not have a record of paying a dividend.

Información clave

n/a

Rentabilidad por dividendo

-28.5%

Rendimiento de la recompra

Rendimiento total para el accionista-28.5%
Rendimiento futuro de los dividendos0%
Crecimiento de los dividendosn/a
Próxima fecha de pago de dividendosn/a
Fecha ex dividendon/a
Dividendo por acciónn/a
Ratio de pagon/a

Últimas actualizaciones de dividendos

No hay actualizaciones

Recent updates

We Think Erasca (NASDAQ:ERAS) Can Afford To Drive Business Growth

Oct 15
We Think Erasca (NASDAQ:ERAS) Can Afford To Drive Business Growth

Erasca: New Focus After Restructuring, But Need More Differentiation

Sep 30

Is Erasca (NASDAQ:ERAS) In A Good Position To Deliver On Growth Plans?

Feb 21
Is Erasca (NASDAQ:ERAS) In A Good Position To Deliver On Growth Plans?

We Think Erasca (NASDAQ:ERAS) Needs To Drive Business Growth Carefully

Nov 16
We Think Erasca (NASDAQ:ERAS) Needs To Drive Business Growth Carefully

Companies Like Erasca (NASDAQ:ERAS) Are In A Position To Invest In Growth

Jun 28
Companies Like Erasca (NASDAQ:ERAS) Are In A Position To Invest In Growth

We Think Erasca (NASDAQ:ERAS) Can Afford To Drive Business Growth

Jan 20
We Think Erasca (NASDAQ:ERAS) Can Afford To Drive Business Growth

Erasca forms clinical trial partnership with Pfizer for cancer therapy

Oct 20

Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation

Sep 23
Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation

Erasca adds 10% ahead of R&D Day

Sep 07

Erasca, Eli Lilly to collaborate on trial to evaluate combo treatment for two cancers

Jul 18

We're Not Very Worried About Erasca's (NASDAQ:ERAS) Cash Burn Rate

Apr 12
We're Not Very Worried About Erasca's (NASDAQ:ERAS) Cash Burn Rate

Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation

Dec 28
Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: Insufficient data to determine if ERAS's dividends per share have been stable in the past.

Dividendo creciente: Insufficient data to determine if ERAS's dividend payments have been increasing.


Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Erasca vs. Mercado
¿Cómo se compara la rentabilidad por dividendo de ERAS con la del mercado?
SegmentoRentabilidad por dividendo
Empresa (ERAS)n/a
Suelo de mercado 25% (US)1.5%
Techo de mercado 25% (US)4.5%
Media de la industria (Biotechs)2.2%
Analista de previsiones (ERAS) (hasta 3 años)0%

Dividendo destacado: Unable to evaluate ERAS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Alto dividendo: Unable to evaluate ERAS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Pago de beneficios a los accionistas

Cobertura de los beneficios: Insufficient data to calculate ERAS's payout ratio to determine if its dividend payments are covered by earnings.


Pago en efectivo a los accionistas

Cobertura de flujo de caja: Unable to calculate sustainability of dividends as ERAS has not reported any payouts.


Descubre empresas que pagan buenos dividendos